A new DRUG TRIALS SNAPSHOT FOR PORTRAZZA is now available. PORTRAZZA is a drug used to treat a type of lung cancer called squamous non-small cell lung cancer (NSCLC) that has become advanced (metastatic). It is to be used in combination with two other cancer drugs, gemcitabine and cisplatin, in patients who have not previously received medication to treat advanced lung cancer.
PORTRAZZA is not indicated for treatment of non-squamous non-small cell lung cancer.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.